Thinking of Coming Off Antidepressants?
Thinking of Coming Off Antidepressants?
For many people, antidepressants are an important part of recovery. They can reduce symptoms, improve day-to-day functioning, and create the stability needed to engage in therapy, make lifestyle changes, rebuild relationships, or return to work.
For some, antidepressants remain an important long-term treatment. For others, there comes a point where they begin asking an important question:
"Do I still need this medication?"
Perhaps life is going well. Perhaps you've been well for years. Maybe you're experiencing side effects such as emotional blunting, sexual difficulties, fatigue, or weight gain. You might be planning a pregnancy or simply want to understand who you are without medication.
Whatever the reason, many people assume that stopping an antidepressant will be straightforward.
Sometimes it is.
But sometimes it isn't.
Our understanding of antidepressant withdrawal has changed
For many years, antidepressant withdrawal was thought to be uncommon, mild, and short-lived. Much of this understanding came from clinical trials involving people who had taken antidepressants for relatively short periods, meaning longer-term withdrawal effects were unlikely to be detected (Davies & Read, 2019; Rodriguez, 2019).
Over the past decade, however, research has painted a more nuanced picture.
A systematic review of 14 studies found that around 56% of people experienced withdrawal symptoms when reducing or stopping an antidepressant. Among those who experienced withdrawal, almost half described their symptoms as severe (Davies & Read, 2019). Similar findings have been reflected in more recent reviews and surveys of people reducing antidepressants (Read et al., 2023). And, while many people recovered within days or weeks, a substantial proportion experienced symptoms lasting much longer.
As evidence accumulated, clinical guidance evolved. In 2022, the UK's National Institute for Health and Care Excellence (NICE) updated its recommendations to acknowledge that withdrawal symptoms can sometimes last for several weeks or months and may occasionally be severe.
This doesn't mean everyone will experience difficult withdrawal.
Many people stop antidepressants with relatively few problems.
The challenge is that we cannot yet predict with confidence who will have an easy experience and who may need a slower, more carefully supported approach.
Withdrawal is more than just "feeling low"
Many people imagine withdrawal simply means feeling a bit anxious or down after stopping medication.
In reality, antidepressant withdrawal can involve a wide range of physical, emotional and cognitive symptoms.
These may include:
- dizziness or balance problems
- nausea or flu-like symptoms
- headaches
- tingling sensations or "brain zaps"
- insomnia or vivid dreams
- anxiety or panic
- tearfulness
- irritability
- poor concentration
- memory difficulties
- emotional sensitivity
Withdrawal symptoms may emerge days, weeks or even months after reducing or stopping medication and can, in some people, become more distressing than the symptoms for which the medication was originally prescribed (Read et al., 2023).
Why withdrawal is often mistaken for relapse
One of the biggest challenges is that withdrawal symptoms can resemble symptoms of anxiety of depression.
If someone develops anxiety, low mood or panic after reducing an antidepressant, it is understandable to wonder whether depression or anxiety has returned.
Withdrawal and relapse are two distinct clinical processes that can appear remarkably similar. Careful consideration of when symptoms started, whether physical symptoms are present, how quickly symptoms developed, and whether symptoms improve after reinstating the medication can help distinguish between the two (Horowitz & Taylor, 2022; Sørensen et al., 2022).
Unfortunately, research suggests that withdrawal is still frequently misinterpreted as relapse, leading some people to restart medication unnecessarily or conclude they need antidepressants indefinitely (Guy et al., 2020; Read et al., 2023). In some cases that is true.
In others, it may simply mean the nervous system needed a slower reduction.
Why tapering isn't as simple as cutting tablets in half
Many people are surprised to learn that reducing antidepressants isn't a straightforward mathematical exercise.
You might assume that reducing from 20 mg to 10 mg is the same size step as reducing from 10 mg to 0 mg.
Biologically, it isn't.
The effect antidepressants have on the brain does not reduce in a straight line as the dose decreases. Instead, relatively small reductions at lower doses can produce proportionally much larger changes in serotonin transporter occupancy (Horowitz & Taylor, 2019).
This is why many clinicians now recommend hyperbolic tapering for people who are likely to be more sensitive to withdrawal.
Rather than making equal reductions each time, the reductions become progressively smaller as the dose gets lower.
Think about walking down a staircase.
The first few steps are gentle.
The final step to the ground is often the biggest.
Hyperbolic tapering aims to make those final steps much smaller, giving the nervous system more opportunity to adapt.
Although further prospective research is still needed, this approach has gained increasing support because it better reflects how these medications interact with the brain (Rodriguez, 2019; Wilson & Lader, 2015).
There is no "right" timetable
One of the most common questions people ask is:
"How long will it take me to come off my antidepressant?"
The answer is: it depends.
Factors that may influence withdrawal include:
- how long you've been taking the medication
- which antidepressant you're taking
- your current dose
- whether you've experienced withdrawal previously
- other medications you're taking
- your physical health
- life stressors
- your individual sensitivity
For some people, tapering over several weeks is entirely appropriate.
Others may benefit from reducing over months.
The aim is not to stop as quickly as possible.
The goal is to reduce it at a pace your nervous system can comfortably tolerate (NICE, 2022; Wilson & Lader, 2015).
Why support can make a difference
Coming off an antidepressant is not simply about reducing a dose.
It is also about understanding what your body and mind are experiencing.
Many people understandably become frightened when new symptoms appear. Questions such as:
- Am I relapsing?
- Have I become dependent?
- Will this ever improve?
can increase anxiety and make the experience even more difficult.
A supported taper provides more than just a schedule of dose reductions.
It provides education, monitoring, reassurance, problem-solving, and a structured way of responding if difficulties arise.
A pharmacist can help design a practical tapering plan, identify suitable formulations, and work alongside your prescriber. A psychologist can help you understand symptoms, distinguish possible withdrawal from relapse where appropriate, manage uncertainty, and develop strategies that support recovery throughout the process.
Research consistently shows that people value access to knowledgeable clinicians, psychological support and collaborative tapering plans when reducing antidepressants (Read et al., 2023).
The bottom line
For many people, stopping an antidepressant is relatively straightforward.
For others, it can be unexpectedly challenging.
Neither experience is "normal" or "abnormal"—they simply reflect the fact that people respond differently to medication and to withdrawing from it.
If you're thinking about reducing or stopping your antidepressant, the process deserves the same careful planning and shared decision-making as starting treatment in the first place.
A personalised taper, developed with appropriate professional support, can often make the journey safer, more comfortable, and more likely to succeed.
This article provides general information and is not a substitute for personalised medical advice. Never stop or reduce an antidepressant without discussing your plan with the clinician who prescribes your medication.
References
Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111–121. https://doi.org/10.1016/j.addbeh.2018.08.027
Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020). The patient voice: Patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Therapeutic Advances in Psychopharmacology, 10, 1–15.
Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538–546.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). NICE.
Read, J., Lewis, S., Horowitz, M., & Moncrieff, J. (2023). The need for antidepressant withdrawal support services: Recommendations from 708 patients. Psychiatry Research, 326, 115303.
Rodriguez, T. (2019, December 17). Rethinking antidepressant withdrawal: Expert Q&A. Psychiatry Advisor.
Sørensen, A., Jørgensen, K. J., & Munkholm, K. (2022). Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review. Journal of Affective Disorders, 316, 177–186.
Wilson, E., & Lader, M. (2015). A review of the management of antidepressant discontinuation symptoms. Therapeutic Advances in Psychopharmacology, 5(6), 357–368.